AbbVie
ABBV
#30
Rank
โ‚น25.980 T
Marketcap
โ‚น14,702
Share price
0.10%
Change (1 day)
14.93%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น11.647 Trillion

According to AbbVie's latest financial reports the company's total liabilities are โ‚น11.647 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น10.348 T2.92%
2022-12-31โ‚น10.055 T3.06%
2021-12-31โ‚น9.757 T-2.95%
2020-12-31โ‚น10.053 T44.91%
2019-12-31โ‚น6.937 T46.34%
2018-12-31โ‚น4.740 T13.03%
2017-12-31โ‚น4.194 T0.42%
2016-12-31โ‚น4.176 T27.99%
2015-12-31โ‚น3.263 T99.79%
2014-12-31โ‚น1.633 T7.01%
2013-12-31โ‚น1.526 T17.9%
2012-12-31โ‚น1.294 T222.48%
2011-12-31โ‚น401.45 B64.94%
2010-12-31โ‚น243.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น10.762 T-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.484 T-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.197 T-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.068 T-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.064 T-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.013 T-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.061 T-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น5.437 T-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น69.20 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA